(Q40076893)

17 September 2017

1 reference

title

On chiral drug action (English)

1 reference

17 September 2017

1 reference

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

1 August 2023

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

1 August 2023

author name string

M. Simonyi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6087043

1 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6087043

1 August 2023

publication date

1 July 1984

1 reference

full work available at URL

17 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmed.2610040304

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

https://onlinelibrary.wiley.com/doi/full/10.1002/med.2610040304

1 August 2023

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Medicinal Research Reviews

1 August 2023

published in

1 reference

17 September 2017

volume

4

1 reference

17 September 2017

issue

3

1 reference

17 September 2017

page(s)

359-413

1 reference

On the reaction of cells and of nerve-endings to certain poisons, chiefly as regards the reaction of striated muscle to nicotine and to curari

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040304

Absolute configuration and parasympathetic action: pharmacodynamics of enantiomorphic and diastereoisomeric esters of beta-methylcholine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040304

Three acetylcholine receptors inAplysianeurones

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040304

The inhibitory action of noradrenaline and adrenaline on acetylcholine output by guinea-pig ileum longitudinal muscle strip

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040304

Studies on the relationship between chemical constitution and physiological action: Molecular dissymmetry and physiological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040304

The relevance of β-receptor blockade to ouabain-induced cardiac arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040304

The effect of pindolol on plasma renin activity and blood pressure in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040304

The dissolution times of spherical particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040304

Effect of Propranolol on Oxygen Binding to Hemoglobin In Vitro and In Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040304

Comparative studies of (--)-, (+/-)-propranolol, atenolol, guanethidine, bretylium and tetracaine on adrenergic transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040304

A comparison of some physiological and psychological effects of propranolol and diazepam in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040304

Studies on 1,2,3,4-tetrahydroisoquinolines. IV. .BETA.-Adrenoceptor activity and absolute stereochemistry of (-)-5,7-dihydroxy-1-(3,4,5-trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinoline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040304

Adrenoceptor responsiveness in bronchial asthma: effect of isoprenaline inhalation on plasma cyclic 3',5'-AMP levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040304

Pindolol: A Review of Its Pharmacology, Pharmacokinetics, Clinical Uses, and Adverse Effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040304

Pindolol-a beta-adrenoceptor blocking drug with partial agonist activity: clinical pharmacological considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040304

Pindolol--the pharmacology of a partial agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040304

The alpha- and beta-adrenoceptor blocking potencies of labetalol and its individual stereoisomers in anaesthetized dogs and in isolated tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040304

Receptors mediating some actions of histamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040304

Bromocriptine and dopamine receptor stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040304

On the transmitter function of 5-hydroxytryptamine at excitatory and inhibitory monosynaptic junctions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040304

Pharmacology of cortical inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040304

Pharmacodynamic effects and possible therapeutic uses of THIP, a specific GABA-agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040304

Effect of acute and chronic phenobarbital treatment on GABA and other amino acids contents in seven regions of the rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040304

Benzodiazepines: selective use to avoid addiction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040304

Aggressive behavior and benzodiazepine receptor changes in isolated male mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040304

Inhibition of [3H]adenosine binding by stereoisomers of oxazepam hemisuccinate in guinea-pig brain synaptosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040304

Plasma binding and the affinity of propranolol for a beta receptor in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040304

Unaltered serum propranolol binding by meal-induced variations in fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040304

Increased plasma propranolol binding in myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040304

(+)-Propranolol clearance, an estimation of hepatic blood flow in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040304

Pharmacokinetics and pharmacodynamics of the enantiomers of warfarin in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040304

Educating doctors to use drugs well

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040304

Reduced β-adrenoceptor sensitivity in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040304

Effects of age and cigarette smoking on propranolol disposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040304

Factors affecting drug binding in plasma of elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040304

Factors affecting drug-protein binding in the plasma of newborn infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040304

Preliminary observations on the elimination of acebutolol in severe chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040304

Altered distribution of digoxin in renal failure--a cause of digoxin toxicity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040304

Biotransformation and excretion of lorazepam in patients with chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040304

Renal function, protein binding and pharmacological response to diazoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040304

The effect of end-stage renal failure and haemodialysis on the elimination kinetics of sotalol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040304

Drug advertising in medical journals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040304

Drugs for the Third World

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040304

Simultaneous determination of (–)- and (+)- propranolol by gas chromatography-mass spectrometry using a deuterium labeling technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMED.2610040304

Stereospecific and Nonspecific Interactions of the Morphine Congener Levorphanol in Subcellular Fractions of Mouse Brain

21 January 2018

3

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Quantitation of Beta Adrenergic Receptors in Rat Liver: Confounding Effect of Displaceable But Nonstereospecific Antagonist Binding

1 August 2023

5

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Journal of Pharmacology and Experimental Therapeutics

1 August 2023

9

6

147

Dale

1914

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

The presence of histamine and acetylcholine in the spleen of the ox and the horse

1 August 2023

10

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

1 August 2023

Muscarinic Receptors

14

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Two cyclic analogs of acetylcholine

1 August 2023

16

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Interaction of acetylcholine with different cholinergic nerve receptors

1 August 2023

17

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Structure and activity of acetylcholine

1 August 2023

18

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Antiacetylcholine Drugs: Chemistry, Stereochemistry, and Pharmacology

1 August 2023

21

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Physostigmine, a highly potent antidote for acute experimental diazepam intoxication.

1 August 2023

23

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

The effect of a benzodiazepine, flurazepam, on the response of in vitro skeletal muscle preparations to muscle relaxants: are purines or their receptors involved?

1 August 2023

24

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Scopolamine-induced locomotor stimulation in mice: effect of diazepam and a benzodiazepine antagonist.

1 August 2023

25

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Selective antagonists of benzodiazepines

1 August 2023

26

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Studies on the stereospecificity of closely related compounds which block postganglionic acetylcholine receptors in the guinea-pig ileum

1 August 2023

27

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Pirenzepine distinguishes between different subclasses of muscarinic receptors

1 August 2023

29

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

1 August 2023

30

68

141p

Barlow

1980

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

1 August 2023

31

15

545

Kloog

1979

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Journal of Pharmacology and Experimental Therapeutics

1 August 2023

33

223

219

Wilffert

1982

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Studies of the action of nicotine in guinea-pig tracheal smooth muscle: Interaction with β-adrenoceptor antagonists

1 August 2023

35

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Effects of the optical isomers of propranolol on neuromuscular transmission in the rat

1 August 2023

36

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

1 August 2023

Phencyclidine

39

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

3HPhencyclidine: a probe for the ionic channel of the nicotinic receptor

1 August 2023

40

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Sernyl (CI-395) in clinical anaesthesia.

1 August 2023

41

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Stereospecific binding of 3H-phencyclidine in brain membranes.

1 August 2023

42

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Phencyclidine (angel dust)/sigma "opiate" receptor: visualization by tritium-sensitive film

1 August 2023

43

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Phencyclidine, lysergic acid diethylamide, and mescaline: cerebral artery spasms and hallucinogenic activity

1 August 2023

44

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Certain calcium antagonists are potent displacers of [3H]phencyclidine (PCP) binding in rat brain.

1 August 2023

45

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Verapamil competitively inhibits alpha 1-adrenergic and muscarinic but not beta-adrenergic receptors in rat myocardium

1 August 2023

46

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Ketamine inhibition of ligand binding to cholinergic receptors and ion channels.

1 August 2023

47

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Ketamine alone and combined with diazepam or xylazine in laboratory animals: a 10 year experience

1 August 2023

48

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Ketamine-induced changes in the GABA system of mouse brain.

1 August 2023

49

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Changes in γ-aminobutyric acid-shunt enzymes in regions of rat brain with ketamine anaesthesia

1 August 2023

50

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

1 August 2023

51

22

72

Eldefrawi

1982

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Changes in populations of cholinergic binding sites in brain after chronic exposure to barbital in rats.

1 August 2023

52

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Human brain receptor alterations in suicide victims

1 August 2023

53

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

A Specific Sympathomimetic Ergone in Adrenergic Nerve Fibres (Sympathin) and its Relations to Adrenaline and Nor-Adrenaline

1 August 2023

56

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

1 August 2023

The Catecholamines

59

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

A study of the adrenotropic receptors

1 August 2023

60

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Differentiation of Receptor Systems activated by Sympathomimetic Amines

1 August 2023

62

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Presynaptic regulation of catecholamine release

1 August 2023

63

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

A functional basis for classification of α-adrenergic receptors

1 August 2023

64

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Effects of isoprenaline isomers in man

1 August 2023

65

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Pharmacology of a new adrenergic beta-receptor-blocking compound (Nethalide)

1 August 2023

66

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Beta-adrenergic blocking agents. I. Pronethalol and related N-alkyl and N-aralkyl derivatives of 2-amino-1-(2-naphythyl)ethanol.

1 August 2023

67

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

A NEW ADRENERGIC BETARECEPTOR ANTAGONIST

1 August 2023

68

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Beta-adrenergic blocking agents. 3. The optical isomers of pronethalol, propranolol, and several related compounds

1 August 2023

69

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Optical Isomers of Propranolol

1 August 2023

70

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

.beta.-Adrenergic blocking agents. II. Propranolol and related 3-amino-1-naphthoxy-2-propanols

1 August 2023

71

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Beta-adrenergic blocking agents. 9. Absolute configuration of propranolol and of a number of related aryloxypropanolamines and arylethanolamines

1 August 2023

72

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Beta-adrenergic blocking agents. 10. (3-amino-2-hydroxypropoxy)anilides

1 August 2023

73

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

The effect of d(+)- and 1(-)-practolol on ouabain-induced arrhythmia

1 August 2023

76

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Journal of Pharmacology and Experimental Therapeutics

1 August 2023

77

158

11

Parmley

1967

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

The effect of the dextro isomer of propranolol on sinus rate and cardiac arrhythmias

1 August 2023

78

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Effects of propranolol and a number of its analogues on sodium channels

1 August 2023

80

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Central Hypotensive Activity of dl- and d-Propranolol

1 August 2023

82

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Is the hypotensive effect obtained by application of drugs to the ventral surface of the brain stem due to a membrane stabilizing mechanism? A study with beta-blockers

1 August 2023

83

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

The Effect in Man of (+)-Propranolol and Racemic Propranolol on Renin Secretion Stimulated by Orthostatic Stress

1 August 2023

84

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Studies on the antihypertensive action of the optical isomers of propranolol in man

1 August 2023

85

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Journal of Pharmacology and Experimental Therapeutics

1 August 2023

87

221

453

Atkinson

1982

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

The Role of Renin in the Antihypertensive Action of β-Adrenoreceptor Blocking Agents

1 August 2023

88

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Propranolol effects on autonomic function in hypertensive men

1 August 2023

90

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Isoelectric Heterogeneity of Secreted Renin Differs after β-Adrenergic Stimulation*

1 August 2023

91

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Journal of Pharmacology and Experimental Therapeutics

1 August 2023

94

222

645

Ruffolo

1982

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

American Journal of Physiology

1 August 2023

95

242

f620

Osborn

1982

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Central noradrenergic mechanisms and the cardiovascular effects of intracerebroventricular (+)- and (−)-propranolol in the conscious rabbit

1 August 2023

96

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Journal of Pharmacology and Experimental Therapeutics

1 August 2023

97

192

327

Myers

1975

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Mechanism of action of beta-adrenergic receptor blocking agents in angina pectoris: comparison of action of propranolol with dexpropranolol and practolol.

1 August 2023

98

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Journal of Pharmacology and Experimental Therapeutics

1 August 2023

99

196

517

Kawashima

1976

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Beta-blockers and plasma triglycerides.

1 August 2023

100

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Metabolic consequences of atenolol and propranolol in treatment of essential hypertension

1 August 2023

101

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Effects of racemic, dextro-laevo-propranolol and isoxuprine on the metabolic and endocrine response to cold in the newborn rabbit

1 August 2023

103

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Inhibition of insulin secretion by aryl-substituted secondary aminoethanols

1 August 2023

104

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Effect of d- and dl-propranolol on glucose-stimulated insulin release

1 August 2023

105

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Systemic and forearm haemodynamic and metabolic effects of racemic propranolol or D-propranolol in healthy subjects

1 August 2023

106

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Effects of autonomic blockade by methylatropine and optical isomers and propranolol on plasma insulin levels in the basal state and after stimulation.

1 August 2023

107

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

D-propranolol and DL-propranolol both decrease conversion of L-thyroxine to L-triiodothyronine

1 August 2023

108

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Propranolol-induced structural changes in human erythrocyte ghost membranes

1 August 2023

111

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Atenolol vs. propranolol in essential tremor. A controlled, quantitative study

1 August 2023

114

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Tranquillizing effects of propranolol demonstrated in rats.

1 August 2023

115

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

The anticonvulsant action of the (−)- and (+)-enantiomers of propranolol

1 August 2023

117

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

[The EEG of patients with acute manic psychoses before, during and after treatment with high doses of d-propranolol and dl-propranolol (author's transl)]

1 August 2023

118

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Studies on the structure-activity relationships of adrenergic .BETA.-mimetic benzylamine derivatives. V. 9-Aryl-1H-2,3,7,8,9,10-hexahydrobenzo[d,e]quinolines

1 August 2023

122

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Stereospecific Binding of Propranolol and Catecholamines to the β-Adrenergic Receptor

1 August 2023

124

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Beta-adrenergic receptor: stereospecific interaction of iodinated beta-blocking agent with high affinity site

1 August 2023

125

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Identification of cardiac beta-adrenergic receptors by (minus) [3H]alprenolol binding

1 August 2023

126

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

The beta-adrenergic receptor: rapid purification and covalent labeling by photoaffinity crosslinking

1 August 2023

127

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Characterization of the mammalian beta-2 receptor in 8 M urea

1 August 2023

128

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Intramolecular hydrogen-bonding in beta adrenergic blocking agents

1 August 2023

129

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Increase of myocardial pH by 1- and d-propranolol during ischemia of the heart in dogs.

1 August 2023

130

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Fundamental difference between the molecular interactions of agonists and antagonists with the β-adrenergic receptor

1 August 2023

133

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Evidence favouring the existence of a single adrenergic receptor

1 August 2023

134

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

The beta-adrenergic system and allergic bronchial asthma: changes in lymphocyte beta-adrenergic receptor number and adenylate cyclase activity after an allergen-induced asthmatic attack

1 August 2023

138

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Clinical implications of drug-induced desensitization of the beta receptor after continuous oral use of terbutaline

1 August 2023

140

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Rat lung cholinergic receptor: characterization and regulation by corticosteroids

1 August 2023

141

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Clinical experience of terbutaline in preterm labor

1 August 2023

144

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

A trial of oral ritodrine for the prevention of premature labour

1 August 2023

145

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Ritodrine in the treatment of preterm labour. A clinical trial to compare a standard treatment with three regimens involving the use of ritodrine

1 August 2023

146

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Is the Relaxing Effect of β-Adrenergic Agonists on the Human Myometrium only Transitory?

1 August 2023

147

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Modifications in the regression of the acute inflammation caused by a β-adrenergic effect unbalanced by the α-component (“biased β-effect”)

1 August 2023

152

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration

1 August 2023

153

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Chronic propranolol treatment decreases cardiac β-adrenoceptors in spontaneously hypertensive rats

1 August 2023

154

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Cardiac safety of acute beta blockade: intrinsic sympathomimetic activity is superior to beta-1 selectivity

1 August 2023

159

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Journal of Pharmacology and Experimental Therapeutics

1 August 2023

162

219

447

Ruffolo

1981

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Antihypertensive and adrenergic receptor blocking properties of the enantiomers of medroxalol

1 August 2023

163

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Stereospecificity of the in vitro and in vivo blockade of β-receptors by FM 24, a slowly reversible ligand

1 August 2023

165

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Acta medica Scandinavica. Supplementum

1 August 2023

166

659

191

Kulling

1982

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Definition and antagonism of histamine H 2 -receptors

1 August 2023

168

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Conformation of histamine derivatives. 5. Molecular orbital calculation of the H1-receptor essential conformation of histamine

1 August 2023

169

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Multiple receptors for dopamine

1 August 2023

177

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Biochemical and Physiological Studies of the Beta-Adrenoceptor and the D-2 Dopamine Receptor in the Intermediate Lobe of the Rat Pituitary Gland: A Review

1 August 2023

178

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Stereospecificity of interaction of neuroleptic drugs with neurotransmitters and correlation with clinical potency

1 August 2023

179

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Antagonism by propranolol of central dopamine receptor stimulation is not related to β-adrenergic blockade

1 August 2023

180

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Differential effects of d- and l-propranolol on dopamine turnover stimulated by oxotremorine in striatal and mesolimbic areas of rat brain

1 August 2023

181

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Serotonergic component of neuroleptic receptors

1 August 2023

183

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

1 August 2023

185

16

687

Peroutka

1979

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Direct evidence for an interaction of β-adrenergic blockers with the 5-HT receptor

1 August 2023

186

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

(−)-Propranolol inhibits the behavioural responses of rats to increased 5-hydroxytryptamine in the central nervous system

1 August 2023

187

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Modification by levo-propranolol of tremors induced by harmine in mice

1 August 2023

188

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Antagonism by propranolol of isolation-induced aggression in mice: correlation with 5-hydroxytryptamine receptor blockade

1 August 2023

189

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

1 August 2023

190

68

173p

Connell

1980

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

1 August 2023

191

69

291p

Brownlie

1980

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Propranolol inhibits rat brain monoamine oxidase

1 August 2023

192

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Withdrawal from chronic treatment with metergoline, dl-propranolol and amitriptyline enhances serotonin receptor mediated behaviour in the rat

1 August 2023

193

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Journal of Pharmacology and Experimental Therapeutics

1 August 2023

194

215

582

Peroutka

1980

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Journal of Pharmacology and Experimental Therapeutics

1 August 2023

195

216

142

Peroutka

1981

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Two distinct serotonin receptors: regional variations in receptor binding in mammalian brain

1 August 2023

196

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

The influence of sex hormones on antidepressant-induced alterations in neurotransmitter receptor binding.

1 August 2023

197

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Journal of Pharmacology and Experimental Therapeutics

1 August 2023

198

222

566

Kendall

1982

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Naltrexone, opiate addiction, and endorphins

1 August 2023

199

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Opiate Receptor: Demonstration in Nervous Tissue

1 August 2023

200

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Identification of two related pentapeptides from the brain with potent opiate agonist activity

1 August 2023

201

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Isolation and structure of an untriakontapeptide with opiate activity from camel pituitary glands

1 August 2023

202

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

C fragment of lipotropin has a high affinity for brain opiate receptors

1 August 2023

203

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Multiple opiate receptors in peripheral tissue preparations

1 August 2023

204

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Interconverting mu and delta forms of the opiate receptor in rat striatal patches

1 August 2023

205

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Multiple opiate binding sites in human brain regions: Evidence for κ and σ sites

1 August 2023

206

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

The nature of opiate receptors in toad brain

1 August 2023

207

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Opiate receptor binding sites in human brain

1 August 2023

208

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Enhancement of delta- but not mu-opiate agonist binding by calcium.

1 August 2023

209

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Inhibition of Enkephalin Binding to Opiate Receptors by Zinc Ions: Possible Physiological Importance in the Brain

1 August 2023

210

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Kappa opiate binding sites in human placenta

1 August 2023

211

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Dynorphin Is a Specific Endogenous Ligand of the κ Opioid Receptor

1 August 2023

212

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Comparison of in vitro potencies in pharmacological and binding assays after inhibition of peptides reveals that dynorphin (1–9) is a potent κ-agonist

1 August 2023

213

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

3H-Codeine binding in the guinea pig lower brain stem

1 August 2023

214

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Journal of Pharmacology and Experimental Therapeutics

1 August 2023

217

221

282

Gaddis

1982

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Comparative pharmacology of the optical isomers of ketamine in mice

1 August 2023

218

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

The interaction of ketamine with the opiate receptor

1 August 2023

219

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Journal of Pharmacology and Experimental Therapeutics

1 August 2023

221

202

157

Marietta

1977

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Pharmacology of ketamine isomers in surgical patients.

1 August 2023

222

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Chromatographic separation on phosphocellulose of activated and nonactivated forms of steroid-receptor complex. Purification of the activated complex

1 August 2023

225

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

1 August 2023

227

38

4168

Ojasoo

1978

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Kinetics of the glucocorticoid hormone-receptor interaction. False association constants determined in slowly equilibrating systems

1 August 2023

229

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Kinetics of the hormone-receptor interaction competition experiments with slowly equilibrating ligands

1 August 2023

230

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Determine rate constants of interaction of steroid receptors with non-labelled ligands.

1 August 2023

231

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Dependence of rate constants of the glucocorticoid hormone-receptor interaction on steroid structure

1 August 2023

232

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Neurotransmitter modulation of steroid action in target cells that mediate reproduction and reproductive behavior

1 August 2023

234

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Increase of ovarian progesterone secretion by beta 2-adrenergic stimulation in oestrous rats.

1 August 2023

235

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Diethylstilbestrol regulates the number of α- and β-adrenergic binding sites in incubated hypothalamus and amygdala

1 August 2023

236

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Effects of d-propranolol and estradiol on the cervicovaginal epithelium

1 August 2023

237

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Paradoxical nature of estrogen agonist and antagonist binding in rat liver

1 August 2023

238

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

GABA, bicuculline and central inhibition.

1 August 2023

241

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Bicuculline and Central GABA Receptors

1 August 2023

242

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Configuration and Conformation of Bicuculline, a GABA Antagonist

1 August 2023

243

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Plus and minus-bicuculline methochloride as optical isomers of a GABA antagonist

1 August 2023

244

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Gamma-aminobutyric acid binding to receptor sites in the rat central nervous system.

1 August 2023

246

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Properties of γ-aminobutyric acid (GABA) receptor binding in rat brain synaptic membrane fractions

1 August 2023

247

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

GABA receptor binding with 3H (+) bicuculline–methiodide in rat CNS

1 August 2023

248

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Glial cell function: uptake of transmitter substances

1 August 2023

249

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Localizing 3H-GABA in Nerve Terminals of Rat Cerebral Cortex by Electron Microscopic Autoradiography

1 August 2023

250

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Inhibitors of the GABA uptake systems

1 August 2023

251

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

.gamma.-Aminobutyric acid agonists, antagonists, and uptake inhibitors. Design and therapeutic aspects

1 August 2023

252

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

The Binding of the GAB A Agonist [3H]THIP to Rat Brain Synaptic Membranes

1 August 2023

253

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

High-affinity uptake of (RS)-nipecotic acid in astrocytes cultured from mouse brain. Comparison with GABA transport

1 August 2023

254

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

(-)Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor.

1 August 2023

257

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

3H-baclofen and 3H-GABA bind to bicuculline-insensitive GABAB sites in rat brain

1 August 2023

258

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

1 August 2023

Biological Psychiatry

259

17

877

Kasa

1982

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

GABA--an inhibitory neurotransmitter that is involved in cardiovascular control

1 August 2023

260

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

A relationship between synaptosomal GABA uptake and blood pressure in five inbred strains of mice

1 August 2023

261

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Journal of Pharmacology and Experimental Therapeutics

1 August 2023

262

221

495

Waterhouse

1982

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Nanomolar concentrations of propranolol inhibit GABA-stimulated benzodiazepine binding to rat cerebral cortex.

1 August 2023

263

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

An endogenous protein modulates the affinity of GABA and benzodiazepine receptors in rat brain

1 August 2023

266

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Presence of a low molecular weight endogenous inhibitor on 3H-muscimol binding in synaptic membranes

1 August 2023

267

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

An endogenous substance from porcine brain antagonizes the anticonvulsant effect of diazepam.

1 August 2023

268

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Endogenous GABA determines the characteristics of [3H]GABA-binding

1 August 2023

270

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

1 August 2023

272

19

217

Olsen

1981

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Interaction of barbiturates with dihydropicrotoxinin binding sites related to the GABA receptor-ionophore system

1 August 2023

273

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Dual Action of Pentobarbitone on GABA Binding: Role of Binding Site Integrity

1 August 2023

274

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Modulation of GABA binding sites by CNS depressants and CNS convulsants

1 August 2023

275

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Benzodiazepines: towards more logical use.

1 August 2023

284

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Benzodiazepine receptors in rat brain

1 August 2023

285

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Benzodiazepine receptor: demonstration in the central nervous system

1 August 2023

286

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

High densities of benzodiazepine receptors in human cortical areas

1 August 2023

287

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Identification of inosine and hypoxanthine as endogenous inhibitors of [3H] diazepam binding in the central nervous system

1 August 2023

288

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Competitive inhibition of benzodiazepine binding by fractions from porcine brain

1 August 2023

289

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Identification of an endogenous peptide-ligand for the benzodiazepine receptor.

1 August 2023

290

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Ethyl β-carboline-3-carboxylate shows differential benzodiazepine receptor interaction

1 August 2023

292

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Central Actions of Benzodiazepines: General Introduction

1 August 2023

293

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Biochemical identification of the site of action of benzodiazepines in human brain by 3H-diazepam binding

1 August 2023

295

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Comparison of dihydrodiazepam enantiomers: metabolism, serum binding and brain receptor binding.

1 August 2023

296

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Stimulation of benzodiazepine receptor binding by gamma-aminobutyric acid

1 August 2023

299

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Partial agonists for brain GABA/benzodiazepine receptor complex

1 August 2023

300

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Soluble benzodiazepine receptors: GABAergic regulation

1 August 2023

301

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Isolation of a GABA receptor from bovine brain using a benzodiazepine affinity column

1 August 2023

302

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Resolution of two biochemically and pharmacologically distinct benzodiazepine receptors

1 August 2023

303

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Molecular heterogeneity of benzodiazepine receptors

1 August 2023

304

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

1 August 2023

305

21

618

Hirsch

1982

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Beta-carboline binding indicates the presence of benzodiazepine receptor subclasses in the bovine central nervous system.

1 August 2023

306

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Is stimulation of benzodiazepine receptor binding mediated by a novel GABA receptor?

1 August 2023

307

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Physicochemical Characterization of Detergent-Solubilized gamma-Aminobutyric Acid and Benzodiazepine Receptor Proteins from Bovine Brain

1 August 2023

309

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Location of the site of the tranquillizing action of diazepam by intralimbic application

1 August 2023

310

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Further studies on the site of action of diazepam: anticonvulsant effect in the rabbit

1 August 2023

311

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Anti-anxiety action op diazepam after intraamygdaloid application in the rat

1 August 2023

312

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Anticonflict effect of the benzodiazepines mediated by a GABAergic mechanism in the amygdala.

1 August 2023

313

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Stereospecific benzodiazepine receptor binding by the enantiomers of oxazepam sodium hemisuccinate

1 August 2023

318

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Stereospecificity of esterases hydrolyzing oxazepam acetate

1 August 2023

319

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Brain specific benzodiazepine receptors

1 August 2023

320

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Effects of caffeine and theophylline on adenosine and benzodiazepine receptors in human brain.

1 August 2023

322

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Increase in 3H-flunitrazepam binding in vitro and in vivo to rat brain benzodiazepine receptors by tofizopam, a 3,4-benzodiazepine

1 August 2023

324

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Brain levels of tofizopam in the rat and relationship with benzodiazepine receptors

1 August 2023

325

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Tofizopam modulates the affinity of benzodiazepine receptors in the rat brain.

1 August 2023

326

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

1 August 2023

Pharmacological Reviews

330

1

102

Goldstein

1949

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Plasma and tissue protein binding of drugs in pharmacokinetics

1 August 2023

331

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Binding of psychotropic drugs to isolated alpha-acid glycoprotein

1 August 2023

334

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

The binding characteristics of some adrenergic beta-receptor antagonists to human serum proteins

1 August 2023

335

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

1 August 2023

336

17

187

Glasson

1980

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Disposition of propranolol. VI. Independent variation in steady-state circulating drug concentrations and half-life as a result of plasma drug binding in man.

1 August 2023

337

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Binding of?-adrenoceptor blocking drugs to human serum albumin, to ?1-acid glycoprotein and to human serum

1 August 2023

340

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Effects of cancer and its treatments on plasma concentration of alpha 1-acid glycoprotein and propranolol binding

1 August 2023

341

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Relationship between alpha 1-acid glycoprotein and lidocaine disposition in myocardial infarction.

1 August 2023

342

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Disease-induced changes in the plasma binding of basic drugs

1 August 2023

344

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Journal of Pharmacology and Experimental Therapeutics

1 August 2023

345

182

295

Danon

1972

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

1 August 2023

Pharmacological Reviews

346

33

17

Kragh-Hansen

1981

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Determination of the Vacant Amount of High-Affinity Bilirubin Binding Site on Serum Albumin

1 August 2023

351

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

1 August 2023

354

16

767

Sjöholm

1979

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

The effect of various drugs on the binding of warfarin-14C to human albumin

1 August 2023

355

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Kinetics and clinical importance of displacement of warfarin from albumin by acidic drugs.

1 August 2023

356

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

1 August 2023

357

13

70

Brown

1977

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Comparative biochemistry and physiology

1 August 2023

358

69C

375

Lagercrantz

1981

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Binding of some fatty acids and drugs to immobilized bovine serum albumin studied by column affinity chromatography

1 August 2023

359

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Plasma tryptophan and 5-HT metabolism in the CNS of the newborn rat.

1 August 2023

361

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Characterization of the binding of benzodiazepines to human serum albumin

1 August 2023

362

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

The influence of plasma protein binding on distribution and pharmacological activity of tranquilizers of the benzodiazepine group (author's transl)

1 August 2023

363

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

1 August 2023

365

11

52

Müller

1975

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Spezifikation der molekularen Chiralität

1 August 2023

368

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Interactions of benzodiazepines with human serum albumin. Circular dichroism studies

1 August 2023

371

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Studies on the binding of benzodiazepines to human serum albumin by circular dichroism measurements

1 August 2023

372

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Circular dichroism and gel filtration study of binding of prochiral and chiral 1,4-benzodiazepin-2-ones to human serum albumin

1 August 2023

373

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Stationary ultrafiltration: a radio-tracer technique for studying stereoselective binding of racemic ligands

1 August 2023

377

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Application of ultrafiltration and CD spectroscopy for studying stereoselective binding of racemic ligands.

1 August 2023

378

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Resolution of DL-Tryptophan by Affinity Chromatography on Bovine-Serum Albumin-Agarose Columns

1 August 2023

380

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Resolution by affinity chromatography: stereoselective binding of racemic oxazepam esters to human serum albumin

1 August 2023

381

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Is there a "hydrophobic effect"?

1 August 2023

382

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Stereoselective binding of 4,5-dihydrodiazepam to human serum albumin.

1 August 2023

383

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Stereoselective binding of a 2,3-benzodiazepine to human serum albumin. Effect of conformation on tofizopam binding

1 August 2023

387

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Kinetics of R andS warfarin enantiomers

1 August 2023

388

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Stereoselective disposition and glucuronidation of propranolol in humans

1 August 2023

389

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Stereospecific plasma binding of gliflumide, a new antidiabetic drug

1 August 2023

390

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Receptor for Albumin on the Liver Cell Surface May Mediate Uptake of Fatty Acids and Other Albumin-Bound Substances

1 August 2023

391

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Pharmacokinetics of dextro-, laevo- and racemic propranolol in man.

1 August 2023

393

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Journal of Pharmacology and Experimental Therapeutics

1 August 2023

394

187

581

Branch

1973

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Regional hemodynamic effects of beta-adrenergic blockade with propranolol in the unanesthetized primate

1 August 2023

395

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Journal of Pharmacology and Experimental Therapeutics

1 August 2023

397

213

628

Kawashima

1980

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Propranolol, alprenolol and oxprenolol metabolism in the dog. Identification of N-methylated metabolites

1 August 2023

401

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

1 August 2023

404

7

209

O'Reilly

1971

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Studies on the optical enantiomorphs of warfarin in man

1 August 2023

405

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Warfarin metabolism in man: identification of metabolites in urine

1 August 2023

406

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone

1 August 2023

408

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

The stereoselective interaction of warfarin and metronidazole in man

1 August 2023

410

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Stereoselective interaction of trimethoprim-sulfamethoxazole with the separated enantiomorphs of racemic warfarin in man

1 August 2023

411

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Ticrynafen-racemic warfarin interaction: hepatotoxic or stereoselective?

1 August 2023

412

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Interaction of clofibrate with warfarin. I. Effect of clofibrate on the disposition of the optical enantiomorphs of warfarin

1 August 2023

413

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Dynamic interaction between disulfiram and separated enantiomorphs of racemic warfarin

1 August 2023

414

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Differences in anaesthetic properties between the optical antipodes of hexobarbital in the rat

1 August 2023

416

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Journal of Pharmacology and Experimental Therapeutics

1 August 2023

418

169

153

Furner

1969

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Influence of gender and castration on liver and CNS N-demethylation of morphine in rats.

1 August 2023

419

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Interactions of the Hexobarbital Enantiomers with Rat Liver Microsomes

1 August 2023

420

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Stereochemical characterization of interactions of chiral 1,4-benzodiazepine-2-ones with liver microsomes

1 August 2023

422

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Sclerosing peritonitis, an unusual reaction to a beta-adrenergic-blocking drug (practolol)

1 August 2023

424

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

1 August 2023

Problems with Practolol

425

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

1 August 2023

427

63

351p

Case

1978

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Journal of Pharmacology and Experimental Therapeutics

1 August 2023

428

205

489

Reeves

1978

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Cutaneous and ocular reactions to practolol.

1 August 2023

430

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Toxicity and Teratogenicity of Optical Isomers of Thalidomide

1 August 2023

433

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Age-dependent decrease of alpha 2-adrenergic receptor number in human platelets

1 August 2023

437

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Benzodiazepines in the elderly.

1 August 2023

439

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Kinetics and clinical effects of flurazepam in young and elderly noninsomniacs

1 August 2023

440

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Prediction of creatinine clearance from serum creatinine

1 August 2023

442

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Use of Serum Creatinine Concentrations to Determine Renal Function1

1 August 2023

443

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Letter: Drug-induced illness

1 August 2023

447

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Transfer of propranolol and sotalol across the human placenta. Their effect on maternal and fetal plasma renin activity

1 August 2023

449

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Serum protein binding of drugs and bilirubin in newborn infants and their mothers.

1 August 2023

451

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

The effect of racemic, D-, or L-propranolol and practolol on the response to cold by the newborn rabbit

1 August 2023

458

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Beta-receptor agonists in pregnancy: long term effects in preterm children

1 August 2023

461

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Protein binding of drugs in uremic and normal serum: the role of endogenous binding inhibitors

1 August 2023

467

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

British Journal of Clinical Pharmacology

1 August 2023

470

3

970p

Beeley

1976

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Some β-Adrenoceptor Functions of Therapeutic Interest

1 August 2023

472

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Journal of Pharmacology and Experimental Therapeutics

1 August 2023

478

215

643

Silber

1980

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Solubilization of a mammalian ?-adrenergic receptor

1 August 2023

479

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

1 August 2023

480

19

205

Bürgisser

1981

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Binding characteristics of (+)-, (+/-)- and (-)-[125iodo] cyanopindolol to guinea-pig left ventricle membranes

1 August 2023

481

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

[125I]-HEAT:fifty percent of the ligand can bind to the alpha1-adrenoceptors with extremely high affinity.

1 August 2023

482

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Resolution of (±)‐Propranolol

1 August 2023

483

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

Absolute configuration of glycerol derivatives.3.1 Synthesis and cupra A circular dichroism spectra of some chiral 3-aryloxy-1,2-propanediols and 3-aryloxy-1-amino-2-propanols

1 August 2023

485

1 reference

https://api.crossref.org/works/10.1002/MED.2610040304

1 August 2023

Identifiers

1 reference

17 September 2017

1 reference